Lasa Supergenerics (LASA), pioneer and amongst the leading players in the manufacturing of Veterinary APIs in India through its catalyst chemistry expertise and fully backward integrated unit, has entered into a mutually beneficial tie up with CIDIC.
CIDIC has recognized Lasa Supergenerics as their ‘First Choice Customer’, thus enabling the company to source intermediates at very competitive prices from China & Japan and on longer credit terms. This will also help LASA Supergenerics to source the right material at right price for its products. Further, through this synergistic and symbiotic business association, CIDIC will sell LASA Supergenerics’ finished goods to South East Asian Countries. CIDIC has significant recognition in these territories for supply of quality products.
Lasa Supergenerics manufactures and distributes chemicals. The company offers veterinary API products, animal feed ingredients, and reagents for therapeutic uses.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: